{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:02:18Z","timestamp":1780099338063,"version":"3.54.0"},"reference-count":323,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.autrev.2026.104059","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:48:15Z","timestamp":1777308495000},"page":"104059","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunodeficiency-autoimmunity syndromes"],"prefix":"10.1016","volume":"25","author":[{"given":"Gunnar","family":"Houen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2026.104059_bb0005","series-title":"Janeways immunobiology","author":"Murphy","year":"2017"},{"issue":"1","key":"10.1016\/j.autrev.2026.104059_bb0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00239-024-10155-2","article-title":"Evolution of the major components of innate immunity in animals","volume":"92","author":"Silva","year":"2024","journal-title":"J Mol Evol"},{"key":"10.1016\/j.autrev.2026.104059_bb0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.molimm.2017.02.012","article-title":"The molecular mechanisms of signaling by cooperative assembly formation in innate immunity pathways","volume":"86","author":"Vajjhala","year":"2017","journal-title":"Mol Immunol"},{"key":"10.1016\/j.autrev.2026.104059_bb0020","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.coi.2014.04.003","article-title":"Effects of polymorphisms in immunity-related genes on the immune system and successful aging","volume":"29","author":"Ruan","year":"2014","journal-title":"Curr Opin Immunol"},{"issue":"1\u20132","key":"10.1016\/j.autrev.2026.104059_bb0025","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00251-019-01133-w","article-title":"The IPD project: a centralised resource for the study of polymorphism in genes of the immune system","volume":"72","author":"Maccari","year":"2020","journal-title":"Immunogenetics"},{"issue":"9","key":"10.1016\/j.autrev.2026.104059_bb0030","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41577-023-00843-3","article-title":"Clonal haematopoiesis and dysregulation of the immune system","volume":"23","author":"Belizaire","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2026.104059_bb0035","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.coi.2021.11.003","article-title":"Host genetics of innate immune system in infection","volume":"74","author":"Hsu","year":"2022","journal-title":"Curr Opin Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2026.104059_bb0040","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.it.2016.08.002","article-title":"Shaping variation in the human immune system","volume":"37","author":"Liston","year":"2016","journal-title":"Trends Immunol"},{"issue":"7766","key":"10.1016\/j.autrev.2026.104059_bb0045","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41586-019-1411-0","article-title":"Advances in epigenetics link genetics to the environment and disease","volume":"571","author":"Cavalli","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2026.104059_bb0050","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.21553.1","article-title":"Recent advances in primary immunodeficiency: from molecular diagnosis to treatment","volume":"9","author":"Bucciol","year":"2020","journal-title":"F1000Res"},{"issue":"5","key":"10.1016\/j.autrev.2026.104059_bb0055","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1542\/pir.2017-0308","article-title":"Immunodeficiency disorders","volume":"40","author":"Chinn","year":"2019","journal-title":"Pediatr Rev"},{"issue":"3","key":"10.1016\/j.autrev.2026.104059_bb0060","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41576-023-00656-z","article-title":"Inborn errors of immunity: An expanding universe of disease and genetic architecture","volume":"25","author":"Akalu","year":"2024","journal-title":"Nat Rev Genet"},{"issue":"49","key":"10.1016\/j.autrev.2026.104059_bb0065","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abb1662","article-title":"Human inborn errors of immunity: an expanding universe","volume":"5","author":"Notarangelo","year":"2020","journal-title":"Sci Immunol"},{"issue":"7","key":"10.1016\/j.autrev.2026.104059_bb0070","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s10875-022-01289-3","article-title":"Human inborn errors of immunity: 2022 update on the classification from the international union of immunological societies expert committee","volume":"42","author":"Tangye","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2026.104059_bb0075","series-title":"StatPearls [Internet]","article-title":"Immunodeficiency","author":"Justiz Vaillant","year":"2025"},{"issue":"Suppl. 3","key":"10.1016\/j.autrev.2026.104059_bb0080","article-title":"Secondary immunodeficiency","volume":"20","author":"Pourshahnazari","year":"2025","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2026.104059_bb0085","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2500\/aap.2024.45.240063","article-title":"Overview of secondary immunodeficiency","volume":"45","author":"Herman","year":"2024","journal-title":"Allergy Asthma Proc"},{"issue":"6","key":"10.1016\/j.autrev.2026.104059_bb0090","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.anai.2021.08.413","article-title":"Secondary immunodeficiencies: an overview","volume":"127","author":"Tuano","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2 Suppl 2","key":"10.1016\/j.autrev.2026.104059_bb0095","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1016\/j.jaci.2009.08.040","article-title":"Secondary immunodeficiencies, including HIV infection","volume":"125","author":"Chinen","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.autrev.2026.104059_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103442","article-title":"Autoimmune lymphoproliferative syndrome: a disorder of immune dysregulation","volume":"22","author":"Paskiewicz","year":"2023","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.autrev.2026.104059_bb0105","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/bjh.17850","article-title":"The immune landscape in BCR-ABL negative myeloproliferative neoplasms: inflammation, infections and opportunities for immunotherapy","volume":"196","author":"Strickland","year":"2022","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.autrev.2026.104059_bb0110","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00251-002-0493-1","article-title":"Viral immune evasion: a masterpiece of evolution","volume":"54","author":"Vossen","year":"2002","journal-title":"Immunogenetics"},{"issue":"5\u20136","key":"10.1016\/j.autrev.2026.104059_bb0115","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1159\/000487756","article-title":"Neutrophils and bacterial immune evasion","volume":"10","author":"Kobayashi","year":"2018","journal-title":"J Innate Immun"},{"key":"10.1016\/j.autrev.2026.104059_bb0120","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.3389\/fmicb.2016.02004","article-title":"Hijacking complement regulatory proteins for bacterial immune evasion","volume":"7","author":"Hovingh","year":"2016","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104059_bb0125","doi-asserted-by":"crossref","DOI":"10.1111\/cmi.13272","article-title":"Fungal factors involved in host immune evasion, modulation and exploitation during infection","volume":"23","author":"K\u00f6nig","year":"2021","journal-title":"Cell Microbiol"},{"issue":"6","key":"10.1016\/j.autrev.2026.104059_bb0130","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.tree.2008.02.011","article-title":"Parasite immune evasion: a momentous molecular war","volume":"23","author":"Schmid-Hempel","year":"2008","journal-title":"Trends Ecol Evol"},{"issue":"5","key":"10.1016\/j.autrev.2026.104059_bb0135","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-3083.2010.02386.x","article-title":"Primary immunodeficiency and autoimmunity: lessons from human diseases","volume":"71","author":"Arason","year":"2010","journal-title":"Scand J Immunol"},{"issue":"20","key":"10.1016\/j.autrev.2026.104059_bb0140","doi-asserted-by":"crossref","first-page":"4729","DOI":"10.3390\/jcm10204729","article-title":"Autoimmunity in primary immunodeficiency disorders: An updated review on pathogenic and clinical implications","volume":"10","author":"Costagliola","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2026.104059_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1023127","article-title":"Autoimmunity in monogenic combined immune deficiencies with associated or syndromic features","volume":"13","author":"Sharifinejad","year":"2022","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104059_bb0150","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.clim.2011.05.007","article-title":"Clinical and immunological manifestations of patients with atypical severe combined immunodeficiency","volume":"141","author":"Felgentreff","year":"2011","journal-title":"Clin Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2026.104059_bb0155","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1080\/1744666X.2021.1850272","article-title":"Autoimmunity in common variable immunodeficiency: a systematic review and meta-analysis","volume":"16","author":"Rizvi","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104059_bb0160","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/BOR.0000000000000688","article-title":"Autoimmunity and immunodeficiency","volume":"32","author":"Hoyos-Bachiloglu","year":"2020","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2026.104059_bb0165","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/MOP.0000000000000833","article-title":"Autoimmunity as a continuum in primary immunodeficiency","volume":"31","author":"Walter","year":"2019","journal-title":"Curr Opin Pediatr"},{"issue":"10","key":"10.1016\/j.autrev.2026.104059_bb0170","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1080\/1744666X.2019.1658523","article-title":"Malignancy in common variable immunodeficiency: a systematic review and meta-analysis","volume":"15","author":"Kiaee","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.autrev.2026.104059_bb0175","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jaut.2019.01.011","article-title":"Primary immunodeficiency and autoimmunity: a comprehensive review","volume":"99","author":"Amaya-Uribe","year":"2019","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.autrev.2026.104059_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-022-08942-0","article-title":"Autoimmunity in primary immunodeficiencies (PID)","volume":"65","author":"Padron","year":"2023","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2026.104059_bb0185","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/joim.12395","article-title":"Human autoimmune diseases: a comprehensive update","volume":"278","author":"Wang","year":"2015","journal-title":"J Intern Med"},{"key":"10.1016\/j.autrev.2026.104059_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-8949-2_1","article-title":"Autoantibodies as diagnostic tools","volume":"1901","author":"Houen","year":"2019","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.autrev.2026.104059_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2022.100145","article-title":"Antinuclear antibodies (ANA) as a criterion for classification and diagnosis of systemic autoimmune diseases","volume":"5","author":"Andrade","year":"2022","journal-title":"J Transl Autoimmun"},{"issue":"27","key":"10.1016\/j.autrev.2026.104059_bb0200","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.2174\/1381612825666190709205421","article-title":"Update on autoimmune diseases pathogenesis","volume":"25","author":"Kechida","year":"2019","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.autrev.2026.104059_bb0205","doi-asserted-by":"crossref","DOI":"10.1017\/erm.2014.5","article-title":"Gene-environment interaction in autoimmune disease","volume":"16","author":"Ellis","year":"2014","journal-title":"Expert Rev Mol Med"},{"issue":"7","key":"10.1016\/j.autrev.2026.104059_bb0210","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm.3897","article-title":"Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies","volume":"21","author":"Cho","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2026.104059_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2015.08.015","article-title":"The genetics of human autoimmune disease: a perspective on progress in the field and future directions","volume":"64","author":"Seldin","year":"2015","journal-title":"J Autoimmun"},{"issue":"9","key":"10.1016\/j.autrev.2026.104059_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103610","article-title":"Auto-immuno-deficiency syndromes","volume":"23","author":"Houen","year":"2024","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2026.104059_bb0225","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.1","article-title":"Rheumatoid arthritis","volume":"4","author":"Smolen","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"10.1016\/j.autrev.2026.104059_bb0230","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJMra2103726","article-title":"Rheumatoid arthritis - common origins, divergent mechanisms","volume":"388","author":"Gravallese","year":"2023","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.autrev.2026.104059_bb0235","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/j.immuni.2022.11.009","article-title":"The pathogenesis of rheumatoid arthritis","volume":"55","author":"Alivernini","year":"2022","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.autrev.2026.104059_bb0240","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an american college of rheumatology\/European league against rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"15","key":"10.1016\/j.autrev.2026.104059_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158140","article-title":"Interplay of environmental, individual and genetic factors in rheumatoid arthritis provocation","volume":"23","author":"Arleevskaya","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.autrev.2026.104059_bb0250","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00281-022-00912-0","article-title":"Genetics of rheumatoid arthritis","volume":"44","author":"Padyukov","year":"2022","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.autrev.2026.104059_bb0255","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4103\/jrms.JRMS_567_20","article-title":"Association of the genetic polymorphisms in inhibiting and activating molecules of immune system with rheumatoid arthritis: a systematic review and meta-analysis","volume":"26","author":"Mousavi","year":"2021","journal-title":"J Res Med Sci"},{"key":"10.1016\/j.autrev.2026.104059_bb0260","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.587380","article-title":"Epstein-Barr virus and systemic autoimmune diseases","volume":"11","author":"Houen","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104059_bb0265","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s41927-023-00325-y","article-title":"Vitamin d status and risk of rheumatoid arthritis: systematic review and meta-analysis","volume":"7","author":"Clasen","year":"2023","journal-title":"BMC Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104059_bb0270","first-page":"94","article-title":"Vitamin d deficiency and rheumatoid arthritis: epidemiological, immunological, clinical and therapeutic aspects","volume":"30","author":"Heidari","year":"2019","journal-title":"Mediterr J Rheumatol"},{"key":"10.1016\/j.autrev.2026.104059_bb0275","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-3-319-56017-5_13","article-title":"Role of vitamin d in rheumatoid arthritis","volume":"996","author":"Bellan","year":"2017","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"10.1016\/j.autrev.2026.104059_bb0280","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s12223-023-01036-0","article-title":"Immune dysregulation and pathogenic pathways mediated by common infections in rheumatoid arthritis","volume":"68","author":"Salehi","year":"2023","journal-title":"Folia Microbiol (Praha)"},{"issue":"6","key":"10.1016\/j.autrev.2026.104059_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217624","article-title":"Immunoglobulin g structure and rheumatoid factor epitopes","volume":"14","author":"Maibom-Thomsen","year":"2019","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.autrev.2026.104059_bb0290","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3390\/ijms22020686","article-title":"From rheumatoid factor to anti-Citrullinated protein antibodies and anti-Carbamylated protein antibodies for diagnosis and prognosis prediction in patients with rheumatoid arthritis","volume":"22","author":"Wu","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.autrev.2026.104059_bb0295","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1080\/14737159.2023.2247986","article-title":"Anti-citrullinated protein antibodies as biomarkers in rheumatoid arthritis","volume":"23","author":"Trier","year":"2023","journal-title":"Expert Rev Mol Diagn"},{"issue":"2","key":"10.1016\/j.autrev.2026.104059_bb0300","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s12016-019-08742-z","article-title":"Toll-like receptors, infections, and rheumatoid arthritis","volume":"58","author":"Arleevskaya","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2026.104059_bb0305","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/535738","article-title":"Epstein-Barr virus in systemic autoimmune diseases","volume":"2013","author":"Draborg","year":"2013","journal-title":"Clin Dev Immunol"},{"issue":"11","key":"10.1016\/j.autrev.2026.104059_bb0310","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41584-024-01167-9","article-title":"Epstein-Barr virus as a potentiator of autoimmune diseases","volume":"20","author":"Robinson","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2026.104059_bb0315","doi-asserted-by":"crossref","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","article-title":"Sj\u00f6gren syndrome","volume":"2","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"35","key":"10.1016\/j.autrev.2026.104059_bb0320","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.2174\/1381612824666181016154033","article-title":"From molecular mechanism to the etiology of Sjogren syndrome","volume":"24","author":"Wei","year":"2018","journal-title":"Curr Pharm Des"},{"issue":"3","key":"10.1016\/j.autrev.2026.104059_bb0325","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrrheum.2018.1","article-title":"B cells in the pathogenesis of primary Sj\u00f6gren syndrome","volume":"14","author":"Nocturne","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2026.104059_bb0330","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.clim.2017.04.018","article-title":"Genetics of Sj\u00f6gren's syndrome","volume":"182","author":"Teos","year":"2017","journal-title":"Clin Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2026.104059_bb0335","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.rdc.2016.03.003","article-title":"Genetics in Sj\u00f6gren syndrome","volume":"42","author":"Reksten","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"issue":"6","key":"10.1016\/j.autrev.2026.104059_bb0340","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.autrev.2017.04.004","article-title":"Vitamin d and Sj\u00f6gren syndrome","volume":"16","author":"Garcia-Carrasco","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2026.104059_bb0345","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.823659","article-title":"The role of virus infections in Sj\u00f6gren's syndrome","volume":"13","author":"Maslinska","year":"2022","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.autrev.2026.104059_bb0350","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.3390\/v14071474","article-title":"Virus infections play crucial roles in the pathogenesis of Sj\u00f6gren\u2019s syndrome","volume":"14","author":"Otsuka","year":"2022","journal-title":"Viruses"},{"issue":"12","key":"10.1016\/j.autrev.2026.104059_bb0355","first-page":"2387","article-title":"Candidate autoantibodies for primary Sj\u00f6gren\u2019s syndrome: where are they now?","volume":"40","author":"He","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2026.104059_bb0360","article-title":"Autoantibodies in Sj\u00f6gren's syndrome and its classification criteria","volume":"5","author":"Veenbergen","year":"2021","journal-title":"J Transl Autoimmun"},{"issue":"2","key":"10.1016\/j.autrev.2026.104059_bb0365","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.autrev.2018.09.003","article-title":"Novel autoantibodies in Sj\u00f6gren\u2019s syndrome: a comprehensive review","volume":"18","author":"Mart\u00edn-Nares","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2026.104059_bb0370","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00296-020-04782-3","article-title":"IgA immunoglobulin isotype of rheumatoid factor in primary Sj\u00f6gren's syndrome","volume":"41","author":"Ma\u015bli\u0144ska","year":"2021","journal-title":"Rheumatol Int"},{"issue":"3","key":"10.1016\/j.autrev.2026.104059_bb0375","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s00784-018-2545-4","article-title":"Clinical and diagnostic significance of serum immunoglobulin a rheumatoid factor in primary Sjogren\u2019s syndrome","volume":"23","author":"Lee","year":"2019","journal-title":"Clin Oral Investig"},{"issue":"11","key":"10.1016\/j.autrev.2026.104059_bb0380","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/art.42270","article-title":"Strong association of combined genetic deficiencies in the classical complement pathway with risk of systemic lupus erythematosus and primary Sj\u00f6gren\u2019s syndrome","volume":"74","author":"Lundtoft","year":"2022","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2026.104059_bb0385","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1006\/clin.1994.1011","article-title":"IgG2 deficiency in primary Sjogren\u2019s syndrome and hypergammaglobulinemic purpura","volume":"70","author":"Eriksson","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.autrev.2026.104059_bb0390","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3389\/fimmu.2017.00885","article-title":"First association of interleukin 12 receptor beta 1 deficiency with Sjogren\u2019s syndrome","volume":"8","author":"Sogkas","year":"2017","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2026.104059_bb0395","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028936","article-title":"Multiple sclerosis pathology","volume":"8","author":"Lassmann","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"10130","key":"10.1016\/j.autrev.2026.104059_bb0400","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","article-title":"Multiple sclerosis","volume":"391","author":"Thompson","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2026.104059_bb0405","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/978-3-031-87919-7_12","article-title":"Oligodendrocyte and myelin pathophysiology in multiple sclerosis","volume":"43","author":"L\u00f3pez-Muguruza","year":"2025","journal-title":"Adv Neurobiol"},{"issue":"4","key":"10.1016\/j.autrev.2026.104059_bb0410","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4132\/jptm.2025.05.20","article-title":"Multiple sclerosis: a practical review for pathologists","volume":"59","author":"Multz","year":"2025","journal-title":"J Pathol Transl Med"},{"issue":"9","key":"10.1016\/j.autrev.2026.104059_bb0415","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S1474-4422(22)00255-1","article-title":"Genetics of multiple sclerosis: lessons from polygenicity","volume":"21","author":"Goris","year":"2022","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.autrev.2026.104059_bb0420","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246157","article-title":"The nature of genetic and environmental susceptibility to multiple sclerosis","volume":"16","author":"Goodin","year":"2021","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.autrev.2026.104059_bb0425","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/1352458519872664","article-title":"Environmental factors and risk of multiple sclerosis: findings from meta-analyses and Mendelian randomization studies","volume":"26","author":"Belbasis","year":"2020","journal-title":"Mult Scler"},{"issue":"2","key":"10.1016\/j.autrev.2026.104059_bb0430","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20020303","article-title":"The interaction between viral and environmental risk factors in the pathogenesis of multiple sclerosis","volume":"20","author":"Tarlinton","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"6578","key":"10.1016\/j.autrev.2026.104059_bb0435","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.autrev.2026.104059_bb0440","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.587078","article-title":"Epstein-Barr virus and multiple sclerosis","volume":"11","author":"Houen","year":"2020","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2026.104059_bb0445","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1080\/1744666X.2021.1847642","article-title":"The role of Epstein-Barr virus in the etiology of multiple sclerosis: a current review","volume":"16","author":"Ruprecht","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2026.104059_bb0450","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jmii.2021.10.009","article-title":"CTLA-4 gene mutation and multiple sclerosis: a case report and literature review","volume":"55","author":"Lin","year":"2022","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.autrev.2026.104059_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2019.101422","article-title":"TNFRSF13C\/BAFFR P21R and H159Y polymorphisms in multiple sclerosis","volume":"37","author":"Ntellas","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.autrev.2026.104059_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(23)00223-4","article-title":"Type 1 diabetes","author":"Quattrin","year":"2023","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.autrev.2026.104059_bb0465","doi-asserted-by":"crossref","first-page":"ITC33","DOI":"10.7326\/AITC202203150","article-title":"Type 1 diabetes mellitus","volume":"175","author":"Syed","year":"2022","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.autrev.2026.104059_bb0470","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2174\/1573399814666180730105351","article-title":"Type 1 diabetes-related autoantibodies in different forms of diabetes","volume":"15","author":"S\u00f8rgjerd","year":"2019","journal-title":"Curr Diabetes Rev"},{"issue":"6","key":"10.1016\/j.autrev.2026.104059_bb0475","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11892-016-0738-2","article-title":"Islet autoantibodies","volume":"16","author":"Lampasona","year":"2016","journal-title":"Curr Diab Rep"},{"issue":"43","key":"10.1016\/j.autrev.2026.104059_bb0480","doi-asserted-by":"crossref","first-page":"17040","DOI":"10.1073\/pnas.0705894104","article-title":"The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes","volume":"104","author":"Wenzlau","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.autrev.2026.104059_bb0485","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S2213-8587(22)00159-0","article-title":"Type 1 diabetes in diverse ancestries and the use of genetic risk scores","volume":"10","author":"Redondo","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104059_bb0490","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4239\/wjd.v11.i1.13","article-title":"Current understandings of the pathogenesis of type 1 diabetes: genetics to environment","volume":"11","author":"Giwa","year":"2020","journal-title":"World J Diabetes"},{"issue":"22","key":"10.1016\/j.autrev.2026.104059_bb0495","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214434","article-title":"Vitamin d and beta cells in type 1 diabetes: a systematic review","volume":"23","author":"Yu","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.autrev.2026.104059_bb0500","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1900\/RDS.2022.18.58","article-title":"Vitamin d deficiency as a possible cause of type 1 diabetes in children and adolescents up to 15 years old: a systematic review","volume":"18","author":"Daskalopoulou","year":"2022","journal-title":"Rev Diabet Stud"},{"key":"10.1016\/j.autrev.2026.104059_bb0505","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5953562","article-title":"Progress in the relationship between vitamin d deficiency and the incidence of type 1 diabetes mellitus in children","volume":"2022","author":"He","year":"2022","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.autrev.2026.104059_bb0510","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/978-1-4614-5441-0_20","article-title":"Viral infections and diabetes","volume":"771","author":"Galleri","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.autrev.2026.104059_bb0515","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d35","article-title":"Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies","volume":"342","author":"Yeung","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.autrev.2026.104059_bb0520","article-title":"Association between enterovirus infection and type 1 diabetes risk: a meta-analysis of 38 case-control studies","volume":"12","author":"Wang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"10.1016\/j.autrev.2026.104059_bb0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108769","article-title":"Decrease in multiple complement proteins associated with development of islet autoimmunity and type 1 diabetes","volume":"27","author":"Webb-Robertson","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.autrev.2026.104059_bb0530","article-title":"Genome-wide mapping of complement system proteins for islet autoimmunity in the DAISY and TEDDY children","author":"Hu","year":"2025","journal-title":"Res Sq"},{"issue":"9","key":"10.1016\/j.autrev.2026.104059_bb0535","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3899\/jrheum.2023-1209","article-title":"Autoinflammatory diseases: a review","volume":"51","author":"An","year":"2024","journal-title":"J Rheumatol"},{"issue":"3 Pt B","key":"10.1016\/j.autrev.2026.104059_bb0540","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jid.2021.07.189","article-title":"Autoinflammation: interferonopathies and other autoinflammatory diseases","volume":"142","author":"Savic","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2026.104059_bb0545","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2025.1604831","article-title":"The role of innate immune system in respiratory viral infection related asthma","volume":"15","author":"Wu","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.autrev.2026.104059_bb0550","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.928886","article-title":"NOD-like receptors in asthma","volume":"13","author":"Alvarez-Simon","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2026.104059_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2021.100995","article-title":"Cellular and molecular mechanisms of allergic asthma","volume":"85","author":"Koml\u00f3si","year":"2022","journal-title":"Mol Aspects Med"},{"issue":"2","key":"10.1016\/j.autrev.2026.104059_bb0560","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/ACI.0000000000000627","article-title":"The role of atopy in asthma development and persistence","volume":"20","author":"Di Cicco","year":"2020","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2026.104059_bb0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2019.101333","article-title":"Immunologic mechanisms in asthma","volume":"46","author":"Boonpiyathad","year":"2019","journal-title":"Semin Immunol"},{"issue":"9","key":"10.1016\/j.autrev.2026.104059_bb0570","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1111\/all.13788","article-title":"Innate immunity in allergy","volume":"74","author":"Maeda","year":"2019","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.autrev.2026.104059_bb0575","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/ACI.0b013e32833e3163","article-title":"Innate immunity, allergy and atopic dermatitis","volume":"10","author":"Niebuhr","year":"2010","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2026.104059_bb0580","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2026.104059_bb0585","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2025.1617198","article-title":"Oncogenic viruses rewire the epigenome in human cancer","volume":"15","author":"Bautista","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"issue":"10","key":"10.1016\/j.autrev.2026.104059_bb0590","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.3390\/v6104047","article-title":"Human viruses and cancer","volume":"6","author":"Morales-S\u00e1nchez","year":"2014","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.autrev.2026.104059_bb0595","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41577-024-01111-8","article-title":"Cancer immune evasion, immunoediting and intratumour heterogeneity","volume":"25","author":"Roerden","year":"2025","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"10.1016\/j.autrev.2026.104059_bb0600","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.ccell.2024.09.010","article-title":"The hallmarks of cancer immune evasion","volume":"42","author":"Galassi","year":"2024","journal-title":"Cancer Cell"},{"issue":"745","key":"10.1016\/j.autrev.2026.104059_bb0605","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ade4510","article-title":"Electronic health record signatures identify undiagnosed patients with common variable immunodeficiency disease","volume":"16","author":"Johnson","year":"2024","journal-title":"Sci Transl Med"},{"issue":"3","key":"10.1016\/j.autrev.2026.104059_bb0610","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1423-0410.1975.tb00494.x","article-title":"Selective IgA deficiency in blood donors","volume":"29","author":"Koistinen","year":"1975","journal-title":"Vox Sang"},{"issue":"1","key":"10.1016\/j.autrev.2026.104059_bb0615","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/imr.12713","article-title":"RAG gene defects at the verge of immunodeficiency and immune dysregulation","volume":"287","author":"Villa","year":"2019","journal-title":"Immunol Rev"},{"issue":"8","key":"10.1016\/j.autrev.2026.104059_bb0620","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1182\/blood.V99.8.2694","article-title":"Autoimmunity in human primary immunodeficiency diseases","volume":"99","author":"Arkwright","year":"2002","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.autrev.2026.104059_bb0625","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.autrev.2010.02.005","article-title":"Autoimmunity, autoinflammation and lymphoma in combined immunodeficiency (CID)","volume":"9","author":"Schuetz","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2026.104059_bb0630","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s10875-020-00918-z","article-title":"Complete absence of CD3\u03b3 protein expression is responsible for combined immunodeficiency with autoimmunity rather than SCID","volume":"41","author":"Delmonte","year":"2021","journal-title":"J Clin Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2026.104059_bb0635","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaci.2008.09.037","article-title":"Omenn syndrome: inflammation in leaky severe combined immunodeficiency","volume":"122","author":"Villa","year":"2008","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2026.104059_bb0640","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/01.bor.0000231907.50290.6f","article-title":"Omenn syndrome: a lack of tolerance on the background of deficient lymphocyte development and maturation","volume":"18","author":"H\u00f6nig","year":"2006","journal-title":"Curr Opin Rheumatol"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2026.104059_bb0645","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1007\/s10875-007-9159-y","article-title":"Autoimmunity in severe combined immunodeficiency (SCID): lessons from patients and experimental models","volume":"28","author":"Milner","year":"2008","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2026.104059_bb0650","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2147\/TACG.S213920","article-title":"Autoimmunity in Wiskott-Aldrich syndrome: updated perspectives","volume":"14","author":"Sudhakar","year":"2021","journal-title":"Appl Clin Genet"},{"key":"10.1016\/j.autrev.2026.104059_bb0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.108988","article-title":"Hyper IgE syndromes: a clinical approach","volume":"237","author":"Gharehzadehshirazi","year":"2022","journal-title":"Clin Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104059_bb0660","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.jaci.2020.07.024","article-title":"Lupus-like autoimmunity and increased interferon response in patients with STAT3-deficient hyper-IgE syndrome","volume":"147","author":"Goel","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2026.104059_bb0665","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1080\/15257770.2011.630852","article-title":"Purine nucleoside phosphorylase deficiency: a mutation update","volume":"30","author":"Walker","year":"2011","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"6","key":"10.1016\/j.autrev.2026.104059_bb0670","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10875-014-0056-x","article-title":"Autoimmunity and inflammation in x-linked agammaglobulinemia","volume":"34","author":"Hernandez-Trujillo","year":"2014","journal-title":"J Clin Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2026.104059_bb0675","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jaci.2006.01.038","article-title":"Molecular basis of common variable immunodeficiency","volume":"117","author":"Castigli","year":"2006","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2026.104059_bb0680","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s00431-021-04287-6","article-title":"The pediatric common variable immunodeficiency - from genetics to therapy: a review","volume":"181","author":"Szczawinska-Poplonyk","year":"2022","journal-title":"Eur J Pediatr"},{"issue":"2","key":"10.1016\/j.autrev.2026.104059_bb0685","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.aller.2017.04.004","article-title":"Autoimmunity and its association with regulatory t cells and b cell subsets in patients with common variable immunodeficiency","volume":"46","author":"Azizi","year":"2018","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"9","key":"10.1016\/j.autrev.2026.104059_bb0690","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1159\/000508817","article-title":"Monogenic primary immunodeficiency disorder associated with common variable immunodeficiency and autoimmunity","volume":"181","author":"Asgardoon","year":"2020","journal-title":"Int Arch Allergy Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104059_bb0695","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12016-019-08756-7","article-title":"The epidemiology and clinical manifestations of autoimmunity in selective IgA deficiency","volume":"58","author":"Odineal","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104059_bb0700","first-page":"112","article-title":"Autoimmunity in patients with selective IgA deficiency","volume":"25","author":"Abolhassani","year":"2015","journal-title":"J Invest Allergol Clin Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104059_bb0705","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.autrev.2013.10.005","article-title":"IgA deficiency and autoimmunity","volume":"13","author":"Singh","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.autrev.2026.104059_bb0710","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102526","article-title":"Immune dysregulation, polyendocrinopathy, enteropathy, x-linked (IPEX) syndrome: a systematic review","volume":"19","author":"Park","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2026.104059_bb0715","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3389\/fimmu.2012.00211","article-title":"Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome: a paradigm of immunodeficiency with autoimmunity","volume":"3","author":"Barzaghi","year":"2012","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.autrev.2026.104059_bb0720","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1080\/1744666X.2021.1925543","article-title":"Clinical, immunological, and genetic features in 938 patients with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a systematic review","volume":"17","author":"Sharifinejad","year":"2021","journal-title":"Expert Rev Clin Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104059_bb0725","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jaci.2024.09.020","article-title":"JAK-STAT signaling pathway, immunodeficiency, inflammation, immune dysregulation, and inborn errors of immunity","volume":"155","author":"Samra","year":"2025","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2026.104059_bb0730","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1007\/s10875-023-01483-x","article-title":"JAKs and STATs from a clinical perspective: loss-of-function mutations, gain-of-function mutations, and their multidimensional consequences","volume":"43","author":"Ott","year":"2023","journal-title":"J Clin Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2026.104059_bb0735","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jaci.2022.09.002","article-title":"Velas\u2026see abstract for full author list \u2794 Monogenic early-onset lymphoproliferation and autoimmunity: natural history of STAT3 gain-of-function syndrome","volume":"151","author":"Leiding","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2026.104059_bb0740","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2500\/aap.2024.45.240049","article-title":"Immunodeficiency: quantitative and qualitative phagocytic cell defects","volume":"45","author":"Mickey","year":"2024","journal-title":"Allergy Asthma Proc"},{"issue":"8","key":"10.1016\/j.autrev.2026.104059_bb0745","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/cmi.12322","article-title":"Phagocyte NADPH oxidase, chronic granulomatous disease and mycobacterial infections","volume":"16","author":"Deffert","year":"2014","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.autrev.2026.104059_bb0750","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.653932","article-title":"Neutrophil elastase defects in congenital neutropenia","volume":"12","author":"Rydzynska","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2026.104059_bb0755","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jaci.2004.02.001","article-title":"Phagocyte immunodeficiencies and their infections","volume":"113","author":"Rosenzweig","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2026.104059_bb0760","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.molimm.2020.04.019","article-title":"Insights from patients with dendritic cell immunodeficiency","volume":"122","author":"Bigley","year":"2020","journal-title":"Mol Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104059_bb0765","doi-asserted-by":"crossref","first-page":"8305","DOI":"10.1038\/s41598-020-64852-1","article-title":"A panoply of rheumatological manifestations in patients with GATA2 deficiency","volume":"10","author":"Amarnani","year":"2020","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.autrev.2026.104059_bb0770","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/ibd.20449","article-title":"I phagocyte dysfunction and inflammatory bowel disease","volume":"14","author":"Rahman","year":"2008","journal-title":"Inflamm Bowel Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2026.104059_bb0775","first-page":"E17","article-title":"Role of neutrophils in genetic disorders of phagocyte function leading to IBD","volume":"46","author":"Boxer","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.autrev.2026.104059_bb0780","article-title":"Clinical relevance of gain- and loss-of-function germline mutations in STAT1: a systematic review","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2026.104059_bb0785","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jaci.2020.08.017","article-title":"Monogenic autoinflammatory disorders: conceptual overview, phenotype, and clinical approach","volume":"146","author":"Nigrovic","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2026.104059_bb0790","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4081\/reumatismo.2019.1192","article-title":"Adult-onset systemic autoinflammatory disorders: a clinical approach","volume":"71","author":"Borges","year":"2020","journal-title":"Reumatismo"},{"issue":"6","key":"10.1016\/j.autrev.2026.104059_bb0795","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1007\/s10875-022-01287-5","article-title":"DNASE1L3 deficiency, new phenotypes, and evidence for a transient type i IFN signaling","volume":"42","author":"Tusseau","year":"2022","journal-title":"J Clin Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2026.104059_bb0800","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1093\/rheumatology\/keaa450","article-title":"Familial mediterranean fever: the molecular pathways from stress exposure to attacks","volume":"59","author":"Korkmaz","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2026.104059_bb0805","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3389\/fimmu.2019.00763","article-title":"Association of vasculitis and familial mediterranean fever","volume":"10","author":"Abbara","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2026.104059_bb0810","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3390\/encyclopedia1030044","article-title":"Dnase1 family in autoimmunity","volume":"1","author":"Engavale","year":"2021","journal-title":"Encyclopedia"},{"key":"10.1016\/j.autrev.2026.104059_bb0815","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.molimm.2019.08.002","article-title":"Complement deficiencies and dysregulation: pathophysiological consequences, modern analysis, and clinical management","volume":"114","year":"2019","journal-title":"Mol Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2026.104059_bb0820","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2500\/aap.2024.45.240050","article-title":"Immunodeficiency: complement disorders","volume":"45","author":"McMurray","year":"2024","journal-title":"Allergy Asthma Proc"},{"issue":"1","key":"10.1016\/j.autrev.2026.104059_bb0825","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/157488807779316982","article-title":"Function and malfunction of hematopoietic stem cells in primary bone marrow failure syndromes","volume":"2","author":"Risitano","year":"2007","journal-title":"Curr Stem Cell Res Ther"},{"issue":"3","key":"10.1016\/j.autrev.2026.104059_bb0830","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jaci.2024.11.038","article-title":"Somatic mosaicism in genetic errors of immunity","volume":"155","author":"Cooper","year":"2025","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104059_bb0835","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.gendis.2019.09.007","article-title":"An updated review on phenocopies of primary immunodeficiency diseases","volume":"7","author":"Singh","year":"2019","journal-title":"Genes Dis"},{"issue":"7","key":"10.1016\/j.autrev.2026.104059_bb0840","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1080\/1744666X.2023.2208863","article-title":"Cellular mechanisms and clinical applications for phenocopies of inborn errors of immunity: infectious susceptibility due to cytokine autoantibodies","volume":"19","author":"Sun","year":"2023","journal-title":"Expert Rev Clin Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104059_bb0845","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/25785826.2025.2488553","article-title":"Anti-cytokine autoantibodies in human susceptibility to infectious diseases: insights from inborn errors of immunity","volume":"48","author":"Noma","year":"2025","journal-title":"Immunol Med"},{"issue":"5","key":"10.1016\/j.autrev.2026.104059_bb0850","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41590-024-01815-y","article-title":"The ouroboros of autoimmunity","volume":"25","author":"Casanova","year":"2024","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2026.104059_bb0855","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1172\/JCI64096","article-title":"Causes, consequences, and reversal of immune system aging","volume":"123","author":"Montecino-Rodriguez","year":"2013","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.autrev.2026.104059_bb0860","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/s41392-025-02371-z","article-title":"Immunosenescence: signaling pathways, diseases and therapeutic targets","volume":"10","author":"Fu","year":"2025","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"10.1016\/j.autrev.2026.104059_bb0865","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103805","article-title":"Immunosenescence in autoimmune diseases","volume":"24","author":"Hu","year":"2025","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2026.104059_bb0870","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3389\/fimmu.2013.00131","article-title":"The Janus head of T cell aging - autoimmunity and immunodeficiency","volume":"4","author":"Goronzy","year":"2013","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2026.104059_bb0875","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/ajim.20364","article-title":"Immunotoxic effects of chemicals: a matrix for occupational and environmental epidemiological studies","volume":"49","author":"Veraldi","year":"2006","journal-title":"Am J Ind Med"},{"key":"10.1016\/j.autrev.2026.104059_bb0880","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cotox.2017.11.009","article-title":"Environmental xenobiotic exposure and autoimmunity","volume":"10","author":"Pollard","year":"2018","journal-title":"Curr Opin Toxicol"},{"issue":"12","key":"10.1016\/j.autrev.2026.104059_bb0885","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051506","article-title":"Organic solvents as risk factor for autoimmune diseases: a systematic review and meta-analysis","volume":"7","author":"Barrag\u00e1n-Mart\u00ednez","year":"2012","journal-title":"PloS One"},{"issue":"2","key":"10.1016\/j.autrev.2026.104059_bb0890","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/1203475420957950","article-title":"Toward understanding of environmental risk factors in systemic sclerosis","volume":"25","author":"Ouchene","year":"2021","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.autrev.2026.104059_bb0895","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2025.103440","article-title":"Association between occupational and environmental dust exposure and autoimmune diseases: a systematic review and meta-analysis","volume":"154","author":"Lee","year":"2025","journal-title":"J Autoimmun"},{"issue":"3","key":"10.1016\/j.autrev.2026.104059_bb0900","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41584-024-01216-3","article-title":"Occupational dust and chemical exposures and the development of autoimmune rheumatic diseases","volume":"21","author":"Nikpour","year":"2025","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104059_bb0905","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.autrev.2016.09.020","article-title":"Mercury as an environmental stimulus in the development of autoimmunity - a systematic review","volume":"16","author":"Crowe","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.autrev.2026.104059_bb0910","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.2174\/1871530320666191231115437","article-title":"Nickel and skin: from allergy to autoimmunity","volume":"20","author":"Drenovska","year":"2020","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"3","key":"10.1016\/j.autrev.2026.104059_bb0915","first-page":"283","article-title":"The role of environmental factors in autoimmune thyroiditis","volume":"31","author":"Hybenova","year":"2010","journal-title":"Neuro Endocrinol Lett"},{"issue":"2","key":"10.1016\/j.autrev.2026.104059_bb0920","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3390\/ijms26020845","article-title":"Alcohol consumption and autoimmune diseases","volume":"26","author":"Terracina","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"15","key":"10.1016\/j.autrev.2026.104059_bb0925","doi-asserted-by":"crossref","first-page":"7518","DOI":"10.3390\/ijms26157518","article-title":"Perfluoroalkyl substance (PFAS) mixtures drive rheumatoid arthritis risk through immunosuppression: integrating epidemiology and mechanistic evidence","volume":"26","author":"Lv","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.autrev.2026.104059_bb0930","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/ncprheum0655","article-title":"Tobacco smoking and autoimmune rheumatic diseases","volume":"3","author":"Harel-Meir","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2026.104059_bb0935","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1177\/0961203306069344","article-title":"Cigarette smoking and autoimmune disease: what can we learn from epdemiology?","volume":"15","author":"Costenbader","year":"2006","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.autrev.2026.104059_bb0940","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1001\/jamaneurol.2019.4271","article-title":"Association between cigarette smoking and multiple sclerosis: a review","volume":"77","author":"Rosso","year":"2020","journal-title":"JAMA Neurol"},{"issue":"5","key":"10.1016\/j.autrev.2026.104059_bb0945","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.smim.2015.11.001","article-title":"Celiac disease: autoimmunity in response to food antigen","volume":"27","author":"Stamnaes","year":"2015","journal-title":"Semin Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2026.104059_bb0950","first-page":"252","article-title":"Coeliac disease: complications and comorbidities","volume":"22","author":"Ludvigsson","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2026.104059_bb0955","article-title":"Unveiling drug-induced autoimmune-like hepatitis in autoimmune hepatitis patients: a multicenter retrospective study","author":"Arvaniti","year":"2025","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.autrev.2026.104059_bb0960","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jhep.2023.04.033","article-title":"Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): an expert opinion meeting report","volume":"79","author":"Andrade","year":"2023","journal-title":"J Hepatol"},{"issue":"24","key":"10.1016\/j.autrev.2026.104059_bb0965","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.3748\/wjg.v28.i24.2654","article-title":"Drug-induced autoimmune hepatitis: a minireview","volume":"28","author":"Tan","year":"2022","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104059_bb0970","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1177\/08971900211040291","article-title":"Statin-associated autoimmune myopathy: review of the literature","volume":"36","author":"Barrons","year":"2023","journal-title":"J Pharm Pract"},{"issue":"5","key":"10.1016\/j.autrev.2026.104059_bb0975","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3390\/biomedicines12050987","article-title":"Drug-induced myopathies: a comprehensive review and update","volume":"12","author":"Miernik","year":"2024","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.autrev.2026.104059_bb0980","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/BOR.0000000000000522","article-title":"Drug-induced lupus erythematosus: an update on drugs and mechanisms","volume":"30","author":"He","year":"2018","journal-title":"Curr Opin Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2026.104059_bb0985","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.autrev.2018.03.016","article-title":"Drug-induced lupus: traditional and new concepts","volume":"17","author":"Vaglio","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2026.104059_bb0990","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.semarthrit.2018.01.005","article-title":"Hydralazine-associated vasculitis: overlapping features of drug-induced lupus and vasculitis","volume":"48","author":"Kumar","year":"2018","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2026.104059_bb0995","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/BOR.0b013e3282f1331f","article-title":"Drug-induced vasculitis","volume":"20","author":"Wiik","year":"2008","journal-title":"Curr Opin Rheumatol"},{"issue":"10","key":"10.1016\/j.autrev.2026.104059_bb1000","article-title":"Clinical characteristics and management of drug-induced lupus caused by tumor necrosis factor inhibitors: a comprehensive review","volume":"16","author":"Safaei","year":"2024","journal-title":"Cureus"},{"issue":"11","key":"10.1016\/j.autrev.2026.104059_bb1005","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11926-022-01088-0","article-title":"A spotlight on drug-induced vasculitis","volume":"24","author":"Yaseen","year":"2022","journal-title":"Curr Rheumatol Rep"},{"issue":"12","key":"10.1016\/j.autrev.2026.104059_bb1010","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11926-015-0545-9","article-title":"Drug-induced vasculitis: new insights and a changing lineup of suspects","volume":"17","author":"Grau","year":"2015","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"10.1016\/j.autrev.2026.104059_bb1015","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/imr.13247","article-title":"Immune-related adverse events after immune check point inhibitors: understanding the intersection with autoimmunity","volume":"318","author":"Singh","year":"2023","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.autrev.2026.104059_bb1020","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2020.101411","article-title":"Check point inhibitors and autoimmunity: why endocrinopathies and who is prone to?","volume":"34","author":"Percik","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.autrev.2026.104059_bb1025","doi-asserted-by":"crossref","DOI":"10.3390\/cells12101351","article-title":"HIV-host cell interactions","volume":"12","author":"Masenga","year":"2023","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.autrev.2026.104059_bb1030","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijwd.2018.02.002","article-title":"Autoimmune blistering disorders in the setting of human immunodeficiency virus infection","volume":"4","author":"Min","year":"2018","journal-title":"Int J Womens Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2026.104059_bb1035","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/annrheumdis-2016-209815","article-title":"Incidence of autoimmune diseases in a nationwide HIV\/AIDS patient cohort in Taiwan, 2000-2012","volume":"76","author":"Yen","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2026.104059_bb1040","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s12026-015-8767-5","article-title":"Autoimmunity and dysmetabolism of human acquired immunodeficiency syndrome","volume":"64","author":"Huang","year":"2016","journal-title":"Immunol Res"},{"issue":"1 Suppl 48","key":"10.1016\/j.autrev.2026.104059_bb1045","first-page":"S48","article-title":"HIV\/AIDS: epidemic update, new treatment strategies and impact on autoimmunity","volume":"26","author":"Croce","year":"2008","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104059_bb1050","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/01.md.0000159082.45703.90","article-title":"Characteristics of autoimmune thyroid disease occurring as a late complication of immune reconstitution in patients with advanced human immunodeficiency virus (HIV) disease","volume":"84","author":"Chen","year":"2005","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.autrev.2026.104059_bb1055","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00005792-200205000-00005","article-title":"Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy","volume":"81","author":"Shelburne","year":"2002","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.autrev.2026.104059_bb1060","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/00002281-199607000-00012","article-title":"Rheumatic aspects of acquired immunodeficiency syndrome","volume":"8","author":"Itescu","year":"1996","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2026.104059_bb1065","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1651-2227.1994.tb13331.x","article-title":"Autoimmune phenomena in children with human immunodeficiency virus infection and acquired immunodeficiency syndrome","volume":"400","author":"Rodr\u00edguez-Mahou","year":"1994","journal-title":"Acta Paediatr Suppl"},{"issue":"2","key":"10.1016\/j.autrev.2026.104059_bb1070","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-4362.1992.tb03250.x","article-title":"Detection of autoimmunity parameters in the acquired immunodeficiency syndrome (AIDS)","volume":"31","author":"Kyriakis","year":"1992","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2026.104059_bb1075","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1182\/blood.V79.4.954.bloodjournal794954","article-title":"Striking inverse association of IgG-anti-Fab gamma antibodies and CD4 cell counts in patients with acquired immunodeficiency syndrome (AIDS)\/AIDS-related complex","volume":"79","author":"S\u00fcsal","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2026.104059_bb1080","series-title":"Human herpes viruses \u2013 biology, therapy, and immunoprophylaxis","year":"2007"},{"issue":"2","key":"10.1016\/j.autrev.2026.104059_bb1085","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000841","article-title":"Molecular mechanisms of human herpes viruses inferring with host immune surveillance","volume":"8","author":"Jasinski-Bergner","year":"2020","journal-title":"J Immunother Cancer"},{"issue":"12","key":"10.1016\/j.autrev.2026.104059_bb1090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226436","article-title":"Primary Epstein-Barr virus infection with and without infectious mononucleosis","volume":"14","author":"Rostgaard","year":"2019","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.autrev.2026.104059_bb1095","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1186\/s12889-020-09049-x","article-title":"Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom","volume":"20","author":"Kuri","year":"2020","journal-title":"BMC Public Health"},{"issue":"6","key":"10.1016\/j.autrev.2026.104059_bb1100","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.mayocp.2024.09.017","article-title":"Population-based incidence of infectious mononucleosis and related hospitalizations: 2010 through 2021","volume":"100","author":"St Sauver","year":"2025","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.autrev.2026.104059_bb1105","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2174\/1573396320666230801091558","article-title":"Infectious mononucleosis: an updated review","volume":"20","author":"Leung","year":"2024","journal-title":"Curr Pediatr Rev"},{"key":"10.1016\/j.autrev.2026.104059_bb1110","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/370516","article-title":"Epstein-Barr virus and systemic lupus erythematosus","volume":"2012","author":"Draborg","year":"2012","journal-title":"Clin Dev Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104059_bb1115","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28363","article-title":"A common mechanism links Epstein-Barr virus infections and autoimmune diseases","volume":"95","author":"Zhang","year":"2023","journal-title":"J Med Virol"},{"issue":"8","key":"10.1016\/j.autrev.2026.104059_bb1120","doi-asserted-by":"crossref","first-page":"762","DOI":"10.3390\/v11080762","article-title":"Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms","volume":"11","author":"Smatti","year":"2019","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.autrev.2026.104059_bb1125","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/08916930500484708","article-title":"Viruses and autoimmunity","volume":"39","author":"Kim","year":"2006","journal-title":"Autoimmunity"},{"issue":"2","key":"10.1016\/j.autrev.2026.104059_bb1130","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0165-5728(00)00228-9","article-title":"Persisting viruses and autoimmunity","volume":"107","author":"Paroli","year":"2000","journal-title":"J Neuroimmunol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104059_bb1135","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s13317-010-0005-5","article-title":"Virus and autoimmunity","volume":"1","author":"Hepatitis","year":"2010","journal-title":"Auto Immun Highlights"},{"issue":"2","key":"10.1016\/j.autrev.2026.104059_bb1140","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.autrev.2004.12.003","article-title":"T cell immunity in hepatitis b and hepatitis c virus infection: implications for autoimmunity","volume":"4","author":"Ichiki","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2026.104059_bb1145","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.coi.2014.10.006","article-title":"Role of viruses and bacteria-virus interactions in autoimmunity","volume":"31","author":"Steed","year":"2014","journal-title":"Curr Opin Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2026.104059_bb1150","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1099\/0022-1317-49-4-305","article-title":"HLA molecules, bacteria and autoimmunity","volume":"49","author":"Ebringer","year":"2000","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.autrev.2026.104059_bb1155","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2025.1447149","article-title":"A mini review of the pathogenesis of acute rheumatic fever and rheumatic heart disease","volume":"15","author":"Zhuang","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"10.1016\/j.autrev.2026.104059_bb1160","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.GPP3-0045-2018","article-title":"Molecular mimicry, autoimmunity, and infection: the cross-reactive antigens of Group A streptococci and their sequelae","volume":"7","author":"Cunningham","year":"2019","journal-title":"Microbiol Spectrum"},{"issue":"7","key":"10.1016\/j.autrev.2026.104059_bb1165","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11926-021-01015-9","article-title":"The nasal microbiome in ANCA-associated vasculitis: picking the nose for clues on disease pathogenesis","volume":"23","author":"Dekkema","year":"2021","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2026.104059_bb1170","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/858027","article-title":"The influence and role of microbial factors in autoimmune kidney diseases: a systematic review","volume":"2015","author":"Kronbichler","year":"2015","journal-title":"J Immunol Res"},{"issue":"7","key":"10.1016\/j.autrev.2026.104059_bb1175","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1038\/s44321-025-00262-y","article-title":"Interplay between fungal infections and autoimmunity: mechanisms and therapeutic perspectives","volume":"17","author":"DiPalma","year":"2025","journal-title":"EMBO Mol Med"},{"issue":"6","key":"10.1016\/j.autrev.2026.104059_bb1180","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/eji.201041253","article-title":"Mucocutaneous candidiasis and autoimmunity against cytokines in APECED and thymoma patients: clinical and pathogenetic implications","volume":"41","author":"Kisand","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2026.104059_bb1185","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.3389\/fimmu.2018.01842","article-title":"Autoimmunity in chronic chagas disease: a road of multiple pathways to cardiomyopathy?","volume":"9","author":"De Bona","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2026.104059_bb1190","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/B978-0-12-385895-5.00006-2","article-title":"Autoimmunity","volume":"76","author":"Cunha-Neto","year":"2011","journal-title":"Adv Parasitol"},{"issue":"3","key":"10.1016\/j.autrev.2026.104059_bb1195","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0001-706X(00)00099-1","article-title":"Autoimmunity and malaria: what are they doing together?","volume":"76","author":"Daniel-Ribeiro","year":"2000","journal-title":"Acta Trop"},{"key":"10.1016\/j.autrev.2026.104059_bb1200","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.839932","article-title":"Some good and some bad: sand fly salivary proteins in the control of leishmaniasis and in autoimmunity","volume":"12","author":"Aoki","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.autrev.2026.104059_bb1205","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.phrs.2015.08.003","article-title":"Vaccines, adjuvants and autoimmunity","volume":"100","author":"Guimar\u00e3es","year":"2015","journal-title":"Pharmacol Res"},{"issue":"2","key":"10.1016\/j.autrev.2026.104059_bb1210","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/039463201302600201","article-title":"Vaccines and autoimmunity","volume":"26","author":"De Martino","year":"2013","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"10","key":"10.1016\/j.autrev.2026.104059_bb1215","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.autrev.2015.05.014","article-title":"On vaccine\u2019s adjuvants and autoimmunity: current evidence and future perspectives","volume":"14","author":"Pellegrino","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.autrev.2026.104059_bb1220","article-title":"The schematic assessment of vitamin d deficiency in relation to autoimmune disorders and its implications in internal medicine","volume":"17","author":"Aslam","year":"2025","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.autrev.2026.104059_bb1225","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3390\/metabo15040259","article-title":"Vitamin d and its role in rheumatic diseases","volume":"15","author":"Vidal","year":"2025","journal-title":"Metabolites"},{"issue":"3","key":"10.1016\/j.autrev.2026.104059_bb1230","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/phn.13521","article-title":"Unraveling the relationship between vitamin d and noncommunicable diseases: a systemic review and meta-analysis","volume":"42","author":"Dumbre","year":"2025","journal-title":"Public Health Nurs"},{"issue":"11","key":"10.1016\/j.autrev.2026.104059_bb1235","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.3390\/nu16111762","article-title":"Vitamin d: An essential nutrient in the dual relationship between autoimmune thyroid diseases and celiac disease-a comprehensive review","volume":"16","author":"Gorini","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.autrev.2026.104059_bb1240","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/bs.afnr.2023.12.007","article-title":"Vitamin d and viral infections: infectious diseases, autoimmune diseases, and cancers","volume":"109","author":"Grant","year":"2024","journal-title":"Adv Food Nutr Res"},{"key":"10.1016\/j.autrev.2026.104059_bb1245","first-page":"1","article-title":"Vitamin d and immune system","volume":"109","author":"Brown","year":"2024","journal-title":"Adv Food Nutr Res"},{"issue":"1","key":"10.1016\/j.autrev.2026.104059_bb1250","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1146\/annurev-nutr-111324-122456","article-title":"Obesity and autoimmunity epidemic: the role of immunometabolism","volume":"45","author":"Colamatteo","year":"2025","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.autrev.2026.104059_bb1255","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.3389\/fimmu.2019.03141","article-title":"Relationships between vitamin d, gut microbiome, and systemic autoimmunity","volume":"10","author":"Yamamoto","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2026.104059_bb1260","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/978-981-19-7376-5_4","article-title":"Microbiome-induced autoimmunity and novel therapeutic intervention","volume":"1411","author":"Evrensel","year":"2023","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"10.1016\/j.autrev.2026.104059_bb1265","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2021.101506","article-title":"Gut microbiome and thyroid autoimmunity","volume":"35","author":"Virili","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2026.104059_bb1270","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.538130","article-title":"The role of the microbiome in driving RA-related autoimmunity","volume":"8","author":"Rooney","year":"2020","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"10.1016\/j.autrev.2026.104059_bb1275","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/cmi.2018.7","article-title":"The microbiome and autoimmunity: a paradigm from the gut-liver axis","volume":"15","author":"Li","year":"2018","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2026.104059_bb1280","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/BOR.0000000000000394","article-title":"From microbiome to infectome in autoimmunity","volume":"29","author":"Bogdanos","year":"2017","journal-title":"Curr Opin Rheumatol"},{"issue":"10","key":"10.1016\/j.autrev.2026.104059_bb1285","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.3390\/ijms26104818","article-title":"Microbiome markers in gastrointestinal disorders: inflammatory bowel disease, colorectal cancer, and celiac disease","volume":"26","author":"San-Martin","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.autrev.2026.104059_bb1290","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/phar.2481","article-title":"Immunosuppression trends in solid organ transplantation: the future of individualization, monitoring, and management","volume":"41","author":"Pilch","year":"2021","journal-title":"Pharmacotherapy"},{"issue":"11","key":"10.1016\/j.autrev.2026.104059_bb1295","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s40262-020-00923-w","article-title":"Maintenance immunosuppression in solid organ transplantation: integrating novel pharmacodynamic biomarkers to inform calcineurin inhibitor dose selection","volume":"59","author":"Leino","year":"2020","journal-title":"Clin Pharmacokinet"},{"issue":"9","key":"10.1016\/j.autrev.2026.104059_bb1300","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13031","article-title":"Autoimmune hemolytic anemia in solid organ transplantation-the role of immunosuppression","volume":"31","author":"Kanellopoulou","year":"2017","journal-title":"Clin Transpl"},{"key":"10.1016\/j.autrev.2026.104059_bb1305","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1182\/asheducation-2010.1.281","article-title":"Hematologic disorders after solid organ transplantation","volume":"2010","author":"Smith","year":"2010","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"7","key":"10.1016\/j.autrev.2026.104059_bb1310","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.humimm.2008.05.003","article-title":"De novo autoimmunity after organ transplantation: targets and possible pathways","volume":"69","author":"Boros","year":"2008","journal-title":"Hum Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2026.104059_bb1315","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1744-313X.2012.01112.x","article-title":"An important role for autoimmunity in the immunopathogenesis of chronic allograft rejection","volume":"39","author":"Tiriveedhi","year":"2012","journal-title":"Int J Immunogenet"},{"key":"10.1016\/j.autrev.2026.104059_bb1320","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104131","article-title":"Humoral autoimmunity after solid organ transplantation: germinal immunodeficiencyas may not be natural","volume":"354","author":"Siu","year":"2020","journal-title":"Cell Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2026.104059_bb1325","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00011-024-01866-9","article-title":"Bridging the divide: unveiling mutual immunological pathways of cancer and pregnancy","volume":"73","author":"Toadere","year":"2024","journal-title":"Inflamm Res"},{"issue":"7","key":"10.1016\/j.autrev.2026.104059_bb1330","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100759","article-title":"Immune suppression in pregnancy and cancer: parallels and insights","volume":"13","author":"Kareva","year":"2020","journal-title":"Transl Oncol"},{"issue":"6","key":"10.1016\/j.autrev.2026.104059_bb1335","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrendo.2010.46","article-title":"Immunity, thyroid function and pregnancy: molecular mechanisms","volume":"6","author":"Weetman","year":"2010","journal-title":"Nat Rev Endocrinol"},{"issue":"14","key":"10.1016\/j.autrev.2026.104059_bb1340","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1055\/s-0036-1582397","article-title":"Inflammation in complicated pregnancy and its outcome","volume":"33","author":"Kalagiri","year":"2016","journal-title":"Am J Perinatol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104059_bb1345","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2478\/immunohematology-2025-007","article-title":"The rh blood group system: RHD update","volume":"41","author":"Ramsey","year":"2025","journal-title":"Immunohematology"},{"issue":"5","key":"10.1016\/j.autrev.2026.104059_bb1350","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/OGX.0000000000001391","article-title":"Rhesus d prophylaxis: when and why we give rhesus d immunoglobulin","volume":"80","author":"Schwalb","year":"2025","journal-title":"Obstet Gynecol Surv"},{"issue":"10","key":"10.1016\/j.autrev.2026.104059_bb1355","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/ATVBAHA.125.321710","article-title":"Genomic insights at the maternal-fetal interface: preeclampsia subtypes and clinical implications","volume":"45","author":"Solt","year":"2025","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"10.1016\/j.autrev.2026.104059_bb1360","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1161\/ATVBAHA.124.321670","article-title":"Immune mechanisms of vascular disease in preeclampsia","volume":"45","author":"Christensen","year":"2025","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.autrev.2026.104059_bb1365","doi-asserted-by":"crossref","first-page":"164","DOI":"10.12688\/openreseurope.18026.1","article-title":"Gestational diabetes mellitus: unveiling maternal health dynamics from pregnancy through postpartum perspectives","volume":"4","author":"Mora-Ortiz","year":"2024","journal-title":"Open Res Eur"},{"issue":"6","key":"10.1016\/j.autrev.2026.104059_bb1370","doi-asserted-by":"crossref","DOI":"10.1530\/REP-25-0050","article-title":"Pregnancy disorders and maternal consequences: maternal pre-pregnancy risks and postpartum consequences of gestational diabetes","volume":"169","author":"Storey","year":"2025","journal-title":"Reproduction"},{"key":"10.1016\/j.autrev.2026.104059_bb1375","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s13104-015-1177-x","article-title":"Autoimmune diseases and pregnancy: analysis of a series of cases","volume":"8","author":"Gomes","year":"2015","journal-title":"BMC Res Notes"},{"issue":"1","key":"10.1016\/j.autrev.2026.104059_bb1380","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","article-title":"Cold and hot tumors: from molecular mechanisms to targeted therapy","volume":"9","author":"Wu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.autrev.2026.104059_bb1385","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41392-025-02280-1","article-title":"Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches","volume":"10","author":"Tufail","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.autrev.2026.104059_bb1390","first-page":"1","article-title":"Cytokine-driven cancer immune evasion mechanisms","volume":"396","author":"Arenas","year":"2025","journal-title":"Int Rev Cell Mol Biol"},{"issue":"10","key":"10.1016\/j.autrev.2026.104059_bb1395","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.3390\/cancers17101638","article-title":"Immune evasion in cancer metastasis: An unappreciated role of monocytes","volume":"17","author":"Patysheva","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"16","key":"10.1016\/j.autrev.2026.104059_bb1400","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25168899","article-title":"Cracking the codes behind cancer cells\u2019 immune evasion","volume":"25","author":"Mundhara","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2026.104059_bb1405","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123015","article-title":"Cancer stem cell markers: symphonic masters of chemoresistance and immune evasion","volume":"355","author":"Sarabia-S\u00e1nchez","year":"2024","journal-title":"Life Sci"},{"issue":"4","key":"10.1016\/j.autrev.2026.104059_bb1410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevOncog.2024053096","article-title":"Immune evasion in cancer is regulated by tumor-Asociated macrophages (TAMs): targeting TAMs","volume":"29","author":"Jung","year":"2024","journal-title":"Crit Rev Oncog"},{"issue":"5","key":"10.1016\/j.autrev.2026.104059_bb1415","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3390\/biology13050307","article-title":"Current landscape of cancer immunotherapy: harnessing the immune arsenal to overcome immune evasion","volume":"13","author":"Mitra","year":"2024","journal-title":"Biol.-Basel"},{"issue":"1","key":"10.1016\/j.autrev.2026.104059_bb1420","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40164-024-00505-7","article-title":"Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion","volume":"13","author":"Lu","year":"2024","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.autrev.2026.104059_bb1425","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.692940","article-title":"Cancer stem cells: emerging key players in immune evasion of cancers","volume":"9","author":"Lei","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.autrev.2026.104059_bb1430","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.636568","article-title":"Cancer immune evasion through loss of MHC class i antigen presentation","volume":"12","author":"Dhatchinamoorthy","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2026.104059_bb1435","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.autrev.2026.104059_bb1440","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.790113","article-title":"Immunological classification of tumor types and advances in precision combination immunotherapy","volume":"13","author":"Ren","year":"2022","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.autrev.2026.104059_bb1445","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.it.2022.04.010","article-title":"Turning cold tumors hot: from molecular mechanisms to clinical applications","volume":"43","author":"Zhang","year":"2022","journal-title":"Trends Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104059_bb1450","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.trecan.2024.11.011","article-title":"Turning cold into hot: emerging strategies to fire up the tumor microenvironment","volume":"11","author":"Ma","year":"2025","journal-title":"Trends Cancer"},{"key":"10.1016\/j.autrev.2026.104059_bb1455","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1363121","article-title":"Clinical application of immunogenic cell death inducers in cancer immunotherapy: turning cold tumors hot","volume":"12","author":"Han","year":"2024","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"10.1016\/j.autrev.2026.104059_bb1460","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41573-024-00920-9","article-title":"Targeting immunogenic cell stress and death for cancer therapy","volume":"23","author":"Galluzzi","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.autrev.2026.104059_bb1465","article-title":"Chemotherapy-induced immunogenic cell death in combination with ICIs: a brief review of mechanisms, clinical insights, and therapeutic implications","volume":"16","author":"Li","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.autrev.2026.104059_bb1470","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1390263","article-title":"Emerging role of immunogenic cell death in cancer immunotherapy","volume":"15","author":"Arimoto","year":"2024","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2026.104059_bb1475","doi-asserted-by":"crossref","first-page":"275","DOI":"10.5483\/BMBRep.2023-0024","article-title":"Immunogenic cell death in cancer immunotherapy","volume":"56","author":"Choi","year":"2023","journal-title":"BMB Rep"},{"issue":"1","key":"10.1016\/j.autrev.2026.104059_bb1480","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12967-023-04017-6","article-title":"Immunogenic cell death in cancer: concept and therapeutic implications","volume":"21","author":"Galluzzi","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.autrev.2026.104059_bb1485","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-3-319-67577-0_5","article-title":"Immunogenic and non-immunogenic cell death in the tumor microenvironment","volume":"1036","author":"Pitt","year":"2017","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104059_bb1490","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat Rev Immunol"},{"issue":"1\u20133","key":"10.1016\/j.autrev.2026.104059_bb1495","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1387\/ijdb.150061pa","article-title":"Immunogenic cell death","volume":"59","author":"Garg","year":"2015","journal-title":"Int J Dev Biol"},{"issue":"5","key":"10.1016\/j.autrev.2026.104059_bb1500","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1007\/s00210-023-02781-2","article-title":"Effects of chemotherapy on the immune system: implications for cancer treatment and patient outcomes","volume":"397","author":"Sharma","year":"2024","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104059_bb1505","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ijrobp.2023.11.050","article-title":"Radiation therapy and myeloid-derived suppressor cells: breaking down their cancerous partnership","volume":"119","author":"Bergerud","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.autrev.2026.104059_bb1510","first-page":"448","article-title":"The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2","volume":"5","author":"Chaib","year":"2024","journal-title":"Nat Can"},{"key":"10.1016\/j.autrev.2026.104059_bb1515","article-title":"Chemotherapy reinforces anti-tumor immune response and enhances clinical efficacy of immune checkpoint inhibitors","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.autrev.2026.104059_bb1520","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3389\/fonc.2019.01004","article-title":"Chemotherapy-induced tumor cell death at the crossroads between immunogenicity and immunotolerance: focus on acute myeloid leukemia","volume":"9","author":"Ocadlikova","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.autrev.2026.104059_bb1525","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.canlet.2019.04.017","article-title":"Emerging strategies in cancer therapy combining chemotherapy with immunotherapy","volume":"454","author":"Luo","year":"2019","journal-title":"Cancer Lett"},{"issue":"3","key":"10.1016\/j.autrev.2026.104059_bb1530","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2217\/imt.14.111","article-title":"Rationale for combining immunotherapy with chemotherapy","volume":"7","author":"Dalgleish","year":"2015","journal-title":"Immunotherapy"},{"issue":"Suppl. 5","key":"10.1016\/j.autrev.2026.104059_bb1535","doi-asserted-by":"crossref","first-page":"S360","DOI":"10.1093\/cid\/ciu592","article-title":"Immunosuppression associated with novel chemotherapy agents and monoclonal antibodies","volume":"59","author":"Morrison","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.autrev.2026.104059_bb1540","article-title":"Understanding the uncommon: insights into thymoma associated immunodeficiency","author":"Lim","year":"2025","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.autrev.2026.104059_bb1545","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/B978-0-12-823912-4.00008-6","article-title":"Paraneoplastic autoimmune neurologic disorders associated with thymoma","volume":"200","author":"Iorio","year":"2024","journal-title":"Handb Clin Neurol"},{"issue":"12","key":"10.1016\/j.autrev.2026.104059_bb1550","doi-asserted-by":"crossref","first-page":"7571","DOI":"10.21037\/jtd-2019-thym-10","article-title":"Autoimmune disorders and paraneoplastic syndromes in thymoma","volume":"12","author":"Blum","year":"2020","journal-title":"J Thorac Dis"},{"issue":"11","key":"10.1016\/j.autrev.2026.104059_bb1555","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.3390\/cells9112398","article-title":"Chronic lymphocytic leukemia-induced humoral immunosuppression: a systematic review","volume":"9","author":"Grywalska","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.autrev.2026.104059_bb1560","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/978-3-319-04220-6_11","article-title":"Infections in patients with leukemia and lymphoma","volume":"161","author":"Morrison","year":"2014","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.autrev.2026.104059_bb1565","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.738915","article-title":"Secondary immunodeficiency in hematological malignancies: focus on multiple myeloma and chronic lymphocytic leukemia","volume":"12","author":"Allegra","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2026.104059_bb1570","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3324\/haematol.2010.036152","article-title":"Chronic lymphocytic leukemia and autoimmunity: a systematic review","volume":"96","author":"Hodgson","year":"2011","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.autrev.2026.104059_bb1575","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s11864-001-0039-z","article-title":"Autoimmunity in chronic lymphocytic leukemia","volume":"2","author":"Ward","year":"2001","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.autrev.2026.104059_bb1580","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2147\/JBM.S296225","article-title":"Revisiting autoimmunity in chronic lymphocytic leukemia: prognostic value of positive direct antiglobulin test in a retrospective study and literature review","volume":"12","author":"Ahmed","year":"2021","journal-title":"J Blood Med"},{"issue":"2","key":"10.1016\/j.autrev.2026.104059_bb1585","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1586\/1744666X.4.2.247","article-title":"Development of autoimmunity in lymphoma","volume":"4","author":"Jardin","year":"2008","journal-title":"Expert Rev Clin Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2026.104059_bb1590","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1006\/bcmd.2001.0442","article-title":"The dual association between lymphoma and autoimmunity","volume":"27","author":"Ehrenfeld","year":"2001","journal-title":"Blood Cells Mol Dis"},{"issue":"1\u20132","key":"10.1016\/j.autrev.2026.104059_bb1595","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.beha.2016.07.006","article-title":"Marginal zone lymphoma: associated autoimmunity and auto-immune disorders","volume":"30","author":"Teixeira Mendes","year":"2017","journal-title":"Best Pract Res Clin Haematol"},{"issue":"6","key":"10.1016\/j.autrev.2026.104059_bb1600","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/acr2.11668","article-title":"Redox pathogenesis in rheumatic diseases","volume":"6","author":"Laniak","year":"2024","journal-title":"ACR Open Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2026.104059_bb1605","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jaci.2023.12.022","article-title":"Multilayer concept of autoimmune mechanisms and manifestations in inborn errors of immunity: relevance for precision therapy","volume":"153","author":"Seidel","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104059_bb1610","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jaci.2015.11.004","article-title":"The crossroads of autoimmunity and immunodeficiency: lessons from polygenic traits and monogenic defects","volume":"137","author":"Grimbacher","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104059_bb1615","doi-asserted-by":"crossref","DOI":"10.1111\/imr.70091","article-title":"AIRE\u2019s complex role beyond promiscuous gene expression","volume":"337","author":"Peterson","year":"2026","journal-title":"Immunol Rev"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899722600073X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899722600073X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T23:40:07Z","timestamp":1780098007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156899722600073X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":323,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S156899722600073X"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104059","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunodeficiency-autoimmunity syndromes","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104059"}}